Closing Bell: Horizons Marijuana Life Sciences Idx USD down on Tuesday (HMMJ-U)

In trading today, Horizons Marijuana Life Sciences Idx USD shares opened at $8.25 and closed at $7.50. It traded at a low of $7.50 to a high of $8.25.

Shares dipped -11.76% from the previous day's close of $8.50.

During the day across North America, the TSX Composite closed 0.05% at 21885.38, the S&P 500 closed 0.02% at 5071.63, the Dow Jones Industrial Average closed -0.11% at 38460.92 and the Nasdaq Composite closed 0.10% at 15712.75.

Horizons Marijuana Life Sciences Idx USD traded under HMMJ-U on the Toronto Stock Exchange (TSX).

A total of 300 shares was traded during the last trading day, with total trades of 3. On average, Horizons Marijuana Life Sciences Idx USD has traded 545 shares over 5 days and 432 year-to-date.

Trading across the entire TSX saw 1,786 price advancers against 3,411 declines and 112 unchanged.

During the prior 52 weeks, HMMJ-U.TO has traded as high as $8.50 (April 03,2024) and low as $6.26 (November 02,2023). Moreover, in the last 52 weeks, Horizons Marijuana Life Sciences Idx USD's shares have reduced -2.72%, while in 2024, they have gained 7.30%.

Following today's trading, Horizons Marijuana Life Sciences Idx USD has a market capitalization of $0.00 on a float of 0 shares outstanding. Its annual EPS is $None.

Horizons Marijuana Life Sciences Idx USD is a None company headquartered in, None.

The Horizons Marijuana Life Sciences Index ETF seeks to replicate, to the extent possible, the performance of the North American Medical Marijuana Index, net of expenses. The North American Medical Marijuana Index is designed to provide exposure to the performance of a basket of North American publicly listed companies with significant business activities in the marijuana industry.

Horizons Marijuana Life Sciences Idx USD's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..